Beranda › Penyakit Stargardt › Florida
Uji klinis Penyakit Stargardt di Florida
8 studi untuk Penyakit Stargardt mencari peserta di lokasi di Florida.
Kota di Florida
Teks studi resmi (Bahasa Inggris)
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
- University of Florida Health Science Center, Jacksonville
Menerima pesertaFase 1/2
Usia 8 hingga 55 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07161544Study of ALK-001 on the Progression of Stargardt Disease
- Vitreo Retinal Associates, Gainesville
Menerima pesertaFase 3
Usia 8 hingga 45 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07419334A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Florida Health - UF Health Jacksonville, Jacksonville
- University of Miami Health System - Bascom Palmer Eye Institute, Miami
Menerima pesertaStudi observasional
Usia 6 ke atas · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT07425574Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT03011541Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Vitreo Retinal Associates, Gainesville
Menerima pesertaStudi observasional
Usia 5 ke atas · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Des 2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
Menerima pesertaStudi observasional
Usia 12 hingga 65 · Semua jenis kelamin · Diperbarui 19 Sep 2025 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Bascom Palmer Eye Institute, Miami
Menerima pesertaFase 1/2
Usia 12 hingga 65 · Semua jenis kelamin · Diperbarui 29 Apr 2025 · NCT06942572Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.